Our Healthcare News

Recordati Completes the Acquisition of EUSA Pharma

MILAN, Italy—Following the positive outcome of the regulatory clearances process, Recordati announces today the closing of the previously announced acquisition of EUSA Pharma (UK) Ltd(1),…  

Mar 18 2022

Ted Davis to Succeed Amy Tseng as President and CEO of TissueTech

MIAMI—(BUSINESS WIRE)—TissueTech, Inc., a pioneer in the clinical application of cryopreserved human birth tissue products to treat ocular surface disease and disorders, chronic wounds, and…  

Jan 27 2022

VitalConnect Announces Closure of $39 Million Round of Growth Financing

Series E Financing led by EW Healthcare Partners with Robert S White to Join Board

SAN JOSE, California —— VitalConnect®, Inc., a leader…  

Jan 10 2022

Laboratoires Majorelle appoints Alexandre de Germay as Chief Executive Officer

PARIS, France—Laboratoires Majorelle, a fast-growing French specialty pharma company focused on prescription and OTC products in women’s health and urology, today announces the appointment of…  

Oct 20 2021

EW Healthcare Partners Announces the Promotion of Senior Executives

NEW YORK, New York – EW Healthcare Partners (“EW”), a leading healthcare growth equity firm with a global investment practice, has announced the promotion of…  

Oct 04 2021

EW Healthcare Partners Announces the Acquisition of a Majority Stake in Laboratoires Majorelle

London, UNITED KINGDOM—EW Healthcare Partners (“EW”) has acquired a majority stake in Laboratoires Majorelle (“Majorelle”) from its Founders to support its growth and European expansion…  

Apr 30 2021

Bioventus Acquires Bioness, Inc.

DURHAM, North Carolina –– Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, has acquired Bioness, Inc. (“Bioness”),…  

Mar 30 2021

Charles River Laboratories Completes the Acquisition of Cognate BioServices

WILMINGTON, Mass.—(BUSINESS WIRE)—Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it has completed the previously announced acquisition of Cognate BioServices, Inc. for approximately…  

Mar 29 2021

Charles River Laboratories to Acquire Cognate BioServices to Create a Premier Scientific Partner for Cell and Gene Therapy Development

– Significantly Expands Charles River’s Scientific Capabilities in the High-Growth Cell and Gene Therapy Sector –

– Combines Cognate’s Comprehensive Cell and Gene Therapy CDMO…  

Feb 17 2021

View Legacy Fund news >